Curating The Human Genome – What It Will Mean and How We Can Make It Happen

The Human Genome Project, begun in 1990 and completed in 2003, was a major breakthrough for clinical genetics – the sequence of the human genome was no longer a mystery.

Read more

Curation of the Entire Human Genome Requires the Best of Both Human and Artificial Intelligence

Earlier this month, I wrote an opinion article for Technology Networks on how a combination of both human and artificial intelligence technologies have the potential to expedite curation of the entire human genome – and how Genomenon is uniquely suited to address this important challenge.

Read more

Accelerating Rare Disease Diagnosis with Genomic Data

Genomenon CEO, Mike Klein, shares how Mastermind’s new Disease-Specific Curated Content is helping clinicians discover new treatment options for rare diseases.

Read more

Rapid Variant Interpretation with the Mastermind Relevancy Score

The key to rapid and accurate literature curation for clinical interpretation and therapeutic discovery is standardizing and optimizing the review process. The Mastermind Genomic Search Engine meets this need with a collection of sophisticated algorithms that prioritize search results by relevance. This proprietary process is called the Mastermind Relevancy Score.

Read more

Top Three Benefits of Locus-Specific Patient Databases for Rare Disease

In a recent webinar, Genomenon’s chief scientific officer Dr. Mark Kiel was joined by Dr. Gus Khursigara, VP of Medical Affairs and Clinical Strategy at Inozyme Pharma. This blog explores three key benefits of locus-specific patient databases (or Patient Landscapes), and how they are helping Inozyme better understand and target rare diseases.

Read more

Founder Perspective: 7 Lessons from a Genomic Startup

The Keck Graduate Institute Industry Speaker Series helps students explore career options in the life sciences industry by engaging the expertise of professionals from their expansive network. In this blog, Genomenon founder and chief science officer Dr. Mark Kiel summarizes the important lessons he has learned throughout his inspiring transition from academia to entrepreneurship.

Read more